57 related articles for article (PubMed ID: 28360821)
41. Molecular subgroups of medulloblastoma.
Northcott PA; Dubuc AM; Pfister S; Taylor MD
Expert Rev Neurother; 2012 Jul; 12(7):871-84. PubMed ID: 22853794
[TBL] [Abstract][Full Text] [Related]
42. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.
Sikkema AH; den Dunnen WF; Hulleman E; van Vuurden DG; Garcia-Manero G; Yang H; Scherpen FJ; Kampen KR; Hoving EW; Kamps WA; Diks SH; Peppelenbosch MP; de Bont ES
Neuro Oncol; 2012 Sep; 14(9):1125-35. PubMed ID: 22723427
[TBL] [Abstract][Full Text] [Related]
43. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
44. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
[TBL] [Abstract][Full Text] [Related]
45. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Kool M; Korshunov A; Remke M; Jones DT; Schlanstein M; Northcott PA; Cho YJ; Koster J; Schouten-van Meeteren A; van Vuurden D; Clifford SC; Pietsch T; von Bueren AO; Rutkowski S; McCabe M; Collins VP; Bäcklund ML; Haberler C; Bourdeaut F; Delattre O; Doz F; Ellison DW; Gilbertson RJ; Pomeroy SL; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):473-84. PubMed ID: 22358457
[TBL] [Abstract][Full Text] [Related]
46. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
[TBL] [Abstract][Full Text] [Related]
47. Molecular subgroups of medulloblastoma: the current consensus.
Taylor MD; Northcott PA; Korshunov A; Remke M; Cho YJ; Clifford SC; Eberhart CG; Parsons DW; Rutkowski S; Gajjar A; Ellison DW; Lichter P; Gilbertson RJ; Pomeroy SL; Kool M; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):465-72. PubMed ID: 22134537
[TBL] [Abstract][Full Text] [Related]
48. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
[TBL] [Abstract][Full Text] [Related]
49. The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation.
Nojiri K; Iwakawa M; Ichikawa Y; Imadome K; Sakai M; Nakawatari M; Ishikawa K; Ishikawa A; Togo S; Tsujii H; Shimada H; Imai T
Exp Biol Med (Maywood); 2009 Jan; 234(1):112-22. PubMed ID: 18997097
[TBL] [Abstract][Full Text] [Related]
50. Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.
Fiorilli P; Partridge D; Staniszewska I; Wang JY; Grabacka M; So K; Marcinkiewicz C; Reiss K; Khalili K; Croul SE
Lab Invest; 2008 Nov; 88(11):1143-56. PubMed ID: 18794852
[TBL] [Abstract][Full Text] [Related]
51. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
[TBL] [Abstract][Full Text] [Related]
52. Role of cell cycle in mediating sensitivity to radiotherapy.
Pawlik TM; Keyomarsi K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
[TBL] [Abstract][Full Text] [Related]
53. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells.
Nakada M; Niska JA; Miyamori H; McDonough WS; Wu J; Sato H; Berens ME
Cancer Res; 2004 May; 64(9):3179-85. PubMed ID: 15126357
[TBL] [Abstract][Full Text] [Related]
54. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.
Wild-Bode C; Weller M; Rimner A; Dichgans J; Wick W
Cancer Res; 2001 Mar; 61(6):2744-50. PubMed ID: 11289157
[TBL] [Abstract][Full Text] [Related]
55. Polarized expression of the receptor protein tyrosine kinase Cek5 in the developing avian visual system.
Holash JA; Pasquale EB
Dev Biol; 1995 Dec; 172(2):683-93. PubMed ID: 8612982
[TBL] [Abstract][Full Text] [Related]
56. Medulloblastoma cell-substrate interaction in vitro.
Wikstrand CJ; Friedman HS; Bigner DD
Invasion Metastasis; 1991; 11(6):310-24. PubMed ID: 1822845
[TBL] [Abstract][Full Text] [Related]
57. Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.
Bhatia S; Hirsch K; Bukkapatnam S; Baig NA; Oweida A; Griego A; Calame D; Sharma J; Donson A; Foreman N; Albanese C; Venkataraman S; Vibhakar R; Karam SD
Cancer Cell Int; 2017; 17():41. PubMed ID: 28360821
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
